Compile Data Set for Download or QSAR
Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 12413
TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701259(US12122780, Compound 24)
Affinity DataIC50: 2.03nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701260(US12122780, Compound 25)
Affinity DataIC50: 2.75nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701266(US12122780, Compound 34)
Affinity DataIC50: 2.82nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701261(US12122780, Compound 26)
Affinity DataIC50: 3.12nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701250(US12122780, Compound 11)
Affinity DataIC50: 3.26nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701269(US12122780, Compound 37)
Affinity DataIC50: 4.26nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701251(US12122780, Compound 12)
Affinity DataIC50: 5.06nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM50625500(CHEMBL5419352 | US12122780, Compound 39)
Affinity DataIC50: 5.51nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701264(US12122780, Compound 29)
Affinity DataIC50: 6.31nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701258(US12122780, Compound 23)
Affinity DataIC50: 6.46nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701272(US12122780, Compound 41)
Affinity DataIC50: 6.63nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701268(US12122780, Compound 36)
Affinity DataIC50: 7.38nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701265(US12122780, Compound 30)
Affinity DataIC50: 7.48nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701270(US12122780, Compound 38)
Affinity DataIC50: 7.65nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701164(US12122780, Compound 2)
Affinity DataIC50: 10nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701257(US12122780, Compound 22)
Affinity DataIC50: 11nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701267(US12122780, Compound 35)
Affinity DataIC50: 11.6nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701255(US12122780, Compound 19)
Affinity DataIC50: 13.4nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701273(US12122780, Compound 42)
Affinity DataIC50: 15.2nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701249(US12122780, Compound 10)
Affinity DataIC50: 15.7nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701168(US12122780, Compound 3)
Affinity DataIC50: 16nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701253(US12122780, Compound 14)
Affinity DataIC50: 16.2nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701262(US12122780, Compound 27)
Affinity DataIC50: 17.7nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701246(US12122780, Compound 8)
Affinity DataIC50: 21.5nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701248(US12122780, Compound 9)
Affinity DataIC50: 21.8nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701244(US12122780, Compound 6)
Affinity DataIC50: 24.9nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701256(US12122780, Compound 20)
Affinity DataIC50: 26nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701252(US12122780, Compound 13)
Affinity DataIC50: 42nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701154(US12122780, Compound 1)
Affinity DataIC50: 42nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701254(US12122780, Compound 16)
Affinity DataIC50: 45nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701263(US12122780, Compound 28)
Affinity DataIC50: 58nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701257(US12122780, Compound 22)
Affinity DataIC50: 76nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701220(US12122780, Compound 5)
Affinity DataIC50: 131nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Jiangsu Aosaikang Pharmaceutical

US Patent
LigandPNGBDBM701189(US12122780, Compound 4)
Affinity DataIC50: 167nMAssay Description:The kinase buffer in the kit was used to dilute the enzyme, substrate, ATP and inhibitor.The compound to be tested was diluted 5-fold to the eighth c...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent